Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

76.74
-1.2600-1.62%
Volume:160.75K
Turnover:12.88M
Market Cap:512.82M
PE:-24.88
High:84.06
Open:76.70
Low:75.71
Close:78.00
52wk High:105.00
52wk Low:17.09
Shares:6.68M
Float Shares:4.93M
Volume Ratio:0.75
T/O Rate:3.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0842
EPS(LYR):-4.1123
ROE:-26.54%
ROA:-17.99%
PB:3.62
PE(LYR):-18.66

Loading ...

Monopar Therapeutics Shares Fall After Raymond James Downgrade

MT Newswires Live
·
Nov 15

Stock Track | Monopar Therapeutics Plummets 7.48% Following Raymond James Downgrade

Stock Track
·
Nov 14

BTIG Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Nov 14

Monopar Therapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 14

Monopar Therapeutics Q3 EPS $(0.48) Misses $(0.45) Estimate

Benzinga
·
Nov 13

Monopar Therapeutics reports third quarter net loss of $3.4 million

Reuters
·
Nov 13

Press Release: Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Dow Jones
·
Nov 13

Promising Potential of Monopar Therapeutics: Buy Rating Backed by ALXN1840’s Efficacy and Safety Data

TIPRANKS
·
Nov 10

Leerink Partners Initiates Coverage on Monopar Therapeutics With Outperform Rating, $115 Price Target

MT Newswires Live
·
Nov 10

Piper Sandler Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Nov 10

Monopar Therapeutics Initiated at Outperform by Leerink Partners

Dow Jones
·
Nov 10

Monopar Therapeutics Inc : Chardan Capital Markets Raises Target Price to $100 From $85

THOMSON REUTERS
·
Nov 10

Monopar presents new data, analyses from Phase 2 ALXN1840-WD-204 study

TIPRANKS
·
Nov 10

Monopar Therapeutics Reports Rapid Copper Balance Improvement in Wilson Disease Patients with Tiomolybdate Choline

Reuters
·
Nov 09

BTIG Sticks to Its Buy Rating for Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Nov 06

Cantor Fitzgerald Remains a Buy on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Nov 05

Monopar Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
Nov 04

Monopar Therapeutics’ Innovative Imaging Agent Study: Market Implications

TIPRANKS
·
Oct 28

Monopar Announces Abstract Accepted for Oral Presentation at Aasld - the Liver Meeting® 2025

THOMSON REUTERS
·
Oct 15

Monopar Therapeutics Initiated at Overweight by Barclays

Dow Jones
·
Oct 13